Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Drugs for Asthma and COPD Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Drugs for Asthma and COPD Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Generic Drugs
      • 1.3.3 Patented Drugs
    • 1.4 Market Segment by Application
      • 1.4.1 Global Drugs for Asthma and COPD Market Share by Application (2019-2025)
      • 1.4.2 Asthma
      • 1.4.3 COPD
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Drugs for Asthma and COPD Production Value 2014-2025
      • 2.1.2 Global Drugs for Asthma and COPD Production 2014-2025
      • 2.1.3 Global Drugs for Asthma and COPD Capacity 2014-2025
      • 2.1.4 Global Drugs for Asthma and COPD Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Drugs for Asthma and COPD Market Size CAGR of Key Regions
      • 2.2.2 Global Drugs for Asthma and COPD Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Drugs for Asthma and COPD Capacity by Manufacturers
      • 3.1.2 Global Drugs for Asthma and COPD Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Drugs for Asthma and COPD Revenue by Manufacturers (2014-2019)
      • 3.2.2 Drugs for Asthma and COPD Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Drugs for Asthma and COPD Market Concentration Ratio (CR5 and HHI)
    • 3.3 Drugs for Asthma and COPD Price by Manufacturers
    • 3.4 Key Manufacturers Drugs for Asthma and COPD Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Drugs for Asthma and COPD Market
    • 3.6 Key Manufacturers Drugs for Asthma and COPD Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Generic Drugs Production and Production Value (2014-2019)
      • 4.1.2 Patented Drugs Production and Production Value (2014-2019)
    • 4.2 Global Drugs for Asthma and COPD Production Market Share by Type
    • 4.3 Global Drugs for Asthma and COPD Production Value Market Share by Type
    • 4.4 Drugs for Asthma and COPD Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Drugs for Asthma and COPD Consumption by Application

    6 Production by Regions

    • 6.1 Global Drugs for Asthma and COPD Production (History Data) by Regions 2014-2019
    • 6.2 Global Drugs for Asthma and COPD Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Drugs for Asthma and COPD Production Growth Rate 2014-2019
      • 6.3.2 United States Drugs for Asthma and COPD Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Drugs for Asthma and COPD Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Drugs for Asthma and COPD Production Growth Rate 2014-2019
      • 6.4.2 European Union Drugs for Asthma and COPD Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Drugs for Asthma and COPD Import & Export
    • 6.5 China
      • 6.5.1 China Drugs for Asthma and COPD Production Growth Rate 2014-2019
      • 6.5.2 China Drugs for Asthma and COPD Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Drugs for Asthma and COPD Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Drugs for Asthma and COPD Consumption by Regions

    • 7.1 Global Drugs for Asthma and COPD Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Drugs for Asthma and COPD Consumption by Type
      • 7.2.2 United States Drugs for Asthma and COPD Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Drugs for Asthma and COPD Consumption by Type
      • 7.3.2 European Union Drugs for Asthma and COPD Consumption by Application
    • 7.4 China
      • 7.4.1 China Drugs for Asthma and COPD Consumption by Type
      • 7.4.2 China Drugs for Asthma and COPD Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Drugs for Asthma and COPD Consumption by Type
      • 7.5.2 Rest of World Drugs for Asthma and COPD Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 GSK
      • 8.1.1 GSK Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.1.4 Drugs for Asthma and COPD Product Introduction
      • 8.1.5 GSK Recent Development
    • 8.2 Novartis
      • 8.2.1 Novartis Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.2.4 Drugs for Asthma and COPD Product Introduction
      • 8.2.5 Novartis Recent Development
    • 8.3 Merck
      • 8.3.1 Merck Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.3.4 Drugs for Asthma and COPD Product Introduction
      • 8.3.5 Merck Recent Development
    • 8.4 Abbott
      • 8.4.1 Abbott Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.4.4 Drugs for Asthma and COPD Product Introduction
      • 8.4.5 Abbott Recent Development
    • 8.5 Boehringer Ingelheim
      • 8.5.1 Boehringer Ingelheim Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.5.4 Drugs for Asthma and COPD Product Introduction
      • 8.5.5 Boehringer Ingelheim Recent Development
    • 8.6 AstraZeneca
      • 8.6.1 AstraZeneca Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.6.4 Drugs for Asthma and COPD Product Introduction
      • 8.6.5 AstraZeneca Recent Development
    • 8.7 Roche
      • 8.7.1 Roche Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.7.4 Drugs for Asthma and COPD Product Introduction
      • 8.7.5 Roche Recent Development
    • 8.8 Teva
      • 8.8.1 Teva Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.8.4 Drugs for Asthma and COPD Product Introduction
      • 8.8.5 Teva Recent Development
    • 8.9 Vectura
      • 8.9.1 Vectura Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.9.4 Drugs for Asthma and COPD Product Introduction
      • 8.9.5 Vectura Recent Development
    • 8.10 Pfizer
      • 8.10.1 Pfizer Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Drugs for Asthma and COPD
      • 8.10.4 Drugs for Asthma and COPD Product Introduction
      • 8.10.5 Pfizer Recent Development
    • 8.11 Mylan
    • 8.12 Allergan
    • 8.13 Cipla
    • 8.14 Akorn
    • 8.15 Apotex

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Drugs for Asthma and COPD Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Drugs for Asthma and COPD Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Drugs for Asthma and COPD Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Drugs for Asthma and COPD Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Drugs for Asthma and COPD Production Forecast by Type
      • 9.7.2 Global Drugs for Asthma and COPD Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Drugs for Asthma and COPD Sales Channels
      • 10.2.2 Drugs for Asthma and COPD Distributors
    • 10.3 Drugs for Asthma and COPD Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Drugs for Asthma and COPD is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drugs for Asthma and COPD.

      This report studies the global market size of Drugs for Asthma and COPD, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Drugs for Asthma and COPD production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      GSK
      Novartis
      Merck
      Abbott
      Boehringer Ingelheim
      AstraZeneca
      Roche
      Teva
      Vectura
      Pfizer
      Mylan
      Allergan
      Cipla
      Akorn
      Apotex

      Market Segment by Product Type
      Generic Drugs
      Patented Drugs

      Market Segment by Application
      Asthma
      COPD

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Drugs for Asthma and COPD status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Drugs for Asthma and COPD manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Drugs for Asthma and COPD are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now